Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ADAMTS20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POU3F2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FTCDNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DCLK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RBM14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VTI1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXO5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928461 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HS3ST2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEL1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPHA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSPH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCLRE1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ODF3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAMTS9-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on